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Summary
Vascular endothelial growth factor A (VEGF-A) is best known
for its essential roles in blood vessel growth. However,
evidence has emerged that VEGF-A also promotes a wide
range of neuronal functions, both in vitro and in vivo,
including neurogenesis, neuronal migration, neuronal survival
and axon guidance. Recent studies have employed mouse
models to distinguish the direct effects of VEGF on neurons
from its indirect, vessel-mediated effects. Ultimately, refining
our knowledge of VEGF signalling pathways in neurons should
help us to understand how the current use of therapeutics
targeting the VEGF pathway in cancer and eye disease might
be expanded to promote neuronal health and nerve repair.
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Neuronal migration and survival
Introduction
During embryonic development of vertebrates, a multitude of
growth factors and guidance cues cooperate to regulate the
formation of the vascular and neuronal networks that are essential
for tissue homeostasis. The most potent inducer of developmental
blood vessel growth known to date is the dimeric glycoprotein
vascular endothelial growth factor A (VEGF-A, or VEGFA)
(reviewed by Ruhrberg, 2003). VEGF-A is a member of the
cysteine knot family of growth factors, which in mammals also
includes VEGF-B, VEGF-C, VEGF-D (VEGFB, VEGFC, FIGF,
respectively) and placental growth factor (PlGF, or PGF) (Tammela
et al., 2005). In adults, VEGF-A is also important for blood vessel
growth, most notably during organ remodelling and in pathologies
with vascular involvement. For example, it plays a central role in
wound healing, tumour angiogenesis (see Glossary, Box 1) and in
the eye diseases diabetic retinopathy and age-related macular
degeneration (see Glossary, Box 1) (reviewed by Andreoli and
Miller, 2007; Goel et al., 2011). More recently, evidence has
emerged that VEGF-A also plays key roles in neurons. Here, we
discuss recent findings on the vascular and nonvascular roles of
VEGF-A in the nervous system to complement and update several
excellent previous reviews (e.g. Greenberg and Jin, 2005;
Rosenstein and Krum, 2004; Ruiz de Almodovar et al., 2009).
VEGF isoform expression and function
Early in vertebrate development, endothelial cells condense into
blood vessels in a process termed vasculogenesis (see Glossary,
Box 1) (Risau and Flamme, 1995). This process occurs first extra-
embryonically to create the yolk sac vasculature and subsequently
in the embryo proper to give rise to the dorsal aorta, cardinal vein
and pharyngeal arch arteries. Endothelial cell differentiation
depends on VEGF, and vasculogenesis therefore fails when VEGF-
A expression is abolished by gene targeting in the mouse, causing
early embryonic lethality (Carmeliet et al., 1996; Ferrara et al.,
1996).
Throughout most embryonic tissues, VEGF-A is synthesized as a
collection of three major isoforms as a consequence of alternative
splicing; in humans, they consist of 121, 165 or 189 amino acids and
are therefore termed VEGF121, VEGF165 and VEGF189. The
corresponding mouse isoforms are termed VEGF120, VEGF164 and
VEGF188 (Fig. 1A), as they are all one amino acid shorter
(reviewed by Ruhrberg, 2003). Expression of any one of the VEGF-
A isoforms rescues the vascular defects and lethality of the full Vegfa
knockout in mice (Carmeliet et al., 1999; Ruhrberg et al., 2002;
Stalmans et al., 2002). This is explained by the ability of each
isoform to induce endothelial cell differentiation and proliferation
(e.g. Ruhrberg et al., 2002). However, the relative ratio of the
different VEGF-A isoforms varies in different tissues (Ng et al.,
2001) because they have specific roles during the later stages of
vascular development, which relate to their differential affinity for
the extracellular matrix and various VEGF-A receptors. Accordingly,
biochemical assays revealed that the human VEGF189 isoform with
its two heparin-binding domains is retained in the extracellular
matrix after secretion, whereas VEGF165, which contains only one
heparin-binding domain, is partly matrix-bound and partly diffusible;
VEGF121 has no heparin-binding domains and is the most diffusible
isoform (Park et al., 1993). The diffusibility of the isoforms is
thought to reflect their differential affinity for heparan sulphate
proteoglycans (HSPGs) in the extracellular matrix, although genetic
or other physiological evidence that HSPGs are essential for VEGF-
A isoform-induced signalling events is still lacking.
All VEGF-A isoforms bind to the transmembrane tyrosine kinase
receptors VEGFR1 (FLT1) and VEGFR2 (FLK1 or KDR), whereas
the two non-tyrosine kinase receptors of the neuropilin family, NRP1
and NRP2, preferentially bind VEG164 (Fig. 1B) (reviewed by
Ruhrberg, 2003). One recent study reported that VEGF121 also
binds NRP1 in endothelial cells (Pan et al., 2007). However, the
significance of this observation for vessel growth has not yet been
established in vivo and it does not agree with the similarity of
neuronal patterning defects in mice lacking NRP1 or VEGF164 but
expressing VEGF120 (see below).
Below we discuss the roles of VEGF-A signalling in modulating
vascular and neuronal behaviour in the nervous system. For a
discussion of specific intracellular signalling pathways activated by
the various VEGF-A isoforms and their receptors, we refer the
reader to an excellent recent review on this topic (Koch et al.,
2011).
VEGF-A signalling during CNS angiogenesis
The CNS vasculature is essential for brain development
and homeostasis
Like all organs, the central nervous system (CNS) requires a good
vascular supply, both during development and in the adult. The
requirement for blood vessels in the developing CNS is likely to be
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due to the need for delivering oxygen and nutrients to the rapidly
growing and therefore metabolically active CNS tissue.
Accordingly, ablating VEGF-A expression from neural progenitors
and their progeny impairs brain vascularisation and leads to
widespread neuronal apoptosis in the mouse embryo (Breier et al.,
1992; Haigh et al., 2003; Raab et al., 2004). In the adult, reduced
VEGF-A levels in Vegfadelta/delta mice due to mutation of the
hypoxia response element in the Vegfa promoter impairs
neuroprotection; for example, these mutant mice do not recover
motor function after transient spinal cord ischemia, whereas wild-
type littermates show only a transient clinical deficit (Lambrechts
et al., 2003). Moreover, these mutants suffer late-onset motoneuron
degeneration and paralysis, leading to a disease akin to
amyotrophic lateral sclerosis (ALS; see Glossary, Box 1)
(Oosthuyse et al., 2001). Surprisingly, however, adult mice with the
Vegfadelta/delta mutation have a normal capillary density in the CNS
(Osthuyse et al., 2001). This finding raises the possibility that
hypoxia regulation of Vegfa expression is not essential for vascular
development.
Growth factor gradients comprising VEGF-A isoforms
regulate CNS angiogenesis
It was first hypothesized more than 20 years ago that VEGF-A is
released by rapidly growing neuronal precursors to recruit
filopodia-extending blood vessels from perineural vessels into the
brain (Fig. 2A) (Risau, 1997). This idea was corroborated by
genetic studies, which showed that VEGF-A isoforms through their
differential matrix affinities establish chemoattractive gradients,
and that these gradients induce filopodia extension from endothelial
cells at the leading edge of growing brain vessels (Ruhrberg et al.,
2002). In this fashion, VEGF-A isoforms regulate the morphology
and connectivity of capillary networks in the brain (Ruhrberg et al.,
2002). The analysis of endothelial cell behaviour in retinal VEGF-
A gradients (Gerhardt et al., 2003; Ruhrberg et al., 2002) led to the
concept that VEGF-A promotes the migration of filopodia-studded
endothelial tip cells and the proliferation of lumen-forming stalk
cells (reviewed by Geudens and Gerhardt, 2011). Subsequent to
VEGF-induced vessel sprouting, CNS microglia promote fusion of
sprouts into vascular loops (Fig. 2A) in a mechanism that does not
rely on VEGF-A (Fantin et al., 2010).
Distinct roles for different VEGF-A receptors during CNS
angiogenesis
VEGF-induced autophosphorylation of VEGFR2 induces
endothelial cell differentiation, proliferation, migration and survival
(reviewed by Koch et al., 2011; Ruhrberg, 2003). Accordingly,
VEGFR2 is essential for vasculogenesis and angiogenesis in both
the mouse yolk sac and embryo proper (Shalaby et al., 1995).
Function-blocking antibodies specific for VEGFR2 inhibit blood
vessel sprouting in the perinatal retina, demonstrating that
VEGFR2 is also required for CNS vascularisation (e.g. Gerhardt et
al., 2003). Mice lacking the alternative VEGF-A tyrosine kinase
receptor VEGFR1 also have severe vascular defects, but they
include endothelial cell overcrowding and vascular disorganisation
(Fong et al., 1995). This phenotype is not explained by an ability
of VEGFR1 to convey VEGF-A signals in endothelial cells;
instead, VEGFR1 has a higher affinity than VEGFR2 for VEGF-
A and is therefore able to control VEGF-A availability to VEGFR2
(e.g. Hiratsuka et al., 1998; Kearney et al., 2004).
Unlike mice lacking VEGFR1 or VEGFR2, mice lacking
NRP1 survive embryogenesis long enough to form a
multilayered brain and spinal cord; it was therefore possible to
show that this receptor is important for vessel sprouting within
the CNS (Gerhardt et al., 2004; Kawasaki et al., 1999). The most
popular hypothesis of NRP1 function in vessel growth postulates
that VEGF164 binds to NRP1 on endothelial cells to potentiate
VEGFR2 signalling (Soker et al., 1998). Consistent with this
idea, loss of NRP1 from endothelial cells in mice results in
vascular phenotypes that are similar to those of full Nrp1
knockout mice (Gu et al., 2003). Nevertheless, a demonstration
that VEGF-A signalling through NRP1 is essential for
angiogenesis would require an NRP1 mutant specifically
deficient in VEGF-A binding, analogous to the mutant that was
previously created to selectively abolish binding of semaphorins
to NRP1 and that phenocopied the axonal defects of full Nrp1
knockouts (Gu et al., 2003). Although abolishing NRP1 in the
C57BL/6 genetic background causes severe yolk sac vascular
defects and embryonic lethality prior to brain vascularisation at
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Fig. 1. VEGF-A isoforms and their receptors. (A)The mouse Vegfa
gene encodes three major splice forms: VEGF120, VEGF164 and
VEGF188. The yellow boxes represent domains that can each promote
binding to heparin sulphate proteoglycans (HSPGs) in the extracellular
matrix and to the neuropilin cell surface receptors. VEGF120, which
does not possess HSPG-binding domains, is thus able to diffuse over
the greatest distance. (B)The tyrosine kinase receptors VEGFR1 (FLT1),
VEGFR2 (KDR) and the non-tyrosine kinase neuropilin receptors
NRP1/2 bind to different VEGF-A domains (red arrows). Because it
lacks domain 7, VEGF120 is thought not to bind to the neuropilins
effectively.
Box 1. Glossary
Age-related macular degeneration. A late-onset eye disorder
characterised by progressive degeneration of the central macula,
leading to loss of central vision.
Amyotrophic lateral sclerosis (ALS). A progressive and fatal
disease characterised by degeneration of upper and lower
motoneurons.
Angiogenesis. The formation of new blood vessels from pre-
existing vessels by sprouting and/or remodelling.
Angiogenic niche of neurogenesis. The existence of new blood
vessels and new neurons in the brain at the same time, in close
proximity and requiring each other.
Commissural axon. An axon that crosses the midline of the neural
tube or its derivatives.
Diabetic retinopathy. An eye condition characterised by
detrimental changes in the retinal vasculature as a complication of
diabetes mellitus.
Neurogenesis. The generation of new neurons from embryonic
neural progenitors or adult neural stem cells.
Subventricular zone (SVZ). A region in the lateral ventricles of the
adult brain containing neural stem cells that supplies new neurons
to the olfactory bulb.
Vasculogenesis. The formation of new blood vessels from single












approximately embryonic day (E) 10.5 (Jones et al., 2008),
losing NRP1 in the JF1 genetic background allows embryos to
survive until ~E14.5 and has enabled the study of VEGF-A
isoform signalling in developing neurons (Schwarz et al., 2004)
(see below). The genetic modifiers of NRP1 signalling in the
different mouse strains have not been identified.
In summary, there is now good experimental evidence to suggest
that the different VEGF-A receptors have essential and
complementary roles in vascular development. However, the
mechanisms that ensure signal integration from these receptors to
promote normal brain vascularisation remain to be identified.
Finally, the physiological significance of NRP2 binding to specific
VEGF-A isoforms has not yet been determined.
Direct roles of VEGF-A in neurons
Increasing evidence shows that VEGF-A can support neural cells
independently of its roles in vessels. Accordingly, VEGF-A is
mitogenic for astroglia and Schwann cells in vitro (e.g. Krum et al.,
2002; Mani et al., 2005; Schratzberger et al., 2000; Silverman et
al., 1999; Sondell et al., 1999a; Sondell et al., 1999b). In addition,
both glial cell types produce a number of different growth factors,
including VEGF-A, to support neuronal growth in explant cultures
(Eddleston and Mucke, 1993; Krum and Rosenstein, 1998). The
observation that VEGF-A treatment increases neurite number,
length and size as well as soma size in primary CNS neuron
cultures lacking glia provided initial evidence that VEGF-A can
directly affect neurons, independently of glia (e.g. Khaibullina et
al., 2004; Rosenstein et al., 2003). Recently, several lines of in vivo
experimentation demonstrated direct and essential roles for VEGF-
A in regulating neural progenitor proliferation, survival, migration,
axon/dendrite patterning and synaptic function.
VEGF-A receptors in neurons
VEGFR2 has been implicated as a VEGF-A receptor for survival
signalling in mature neurons in vitro (e.g. Ogunshola et al.,
2002; Oosthuyse et al., 2001; Sondell et al., 2000). In agreement,
the forced expression of VEGFR2 in motoneurons enhances their
survival in a mouse model of ALS-like motoneuron degeneration
(Storkebaum et al., 2005). However, ablating VEGFR2 in
neuronal progenitors or in their progeny does not obviously
impair brain morphogenesis or viability in the mouse, suggesting
that VEGFR2 does not have a general role in neuronal survival
(Haigh et al., 2003). Instead, VEGFR2 might convey VEGF-A
signals in select subsets of neurons, for example to control axon
pathfinding across the spinal cord midline (see below).
Additionally, VEGFR2 can act in a complex with NRP1 and the
semaphorin receptor plexin D1 to convey semaphorin signals in
axon guidance (Bellon et al., 2010).
The alternative VEGF-A receptor tyrosine kinase VEGFR1 is
expressed in several types of developing and adult neurons (e.g.
Islamov et al., 2004; Yang et al., 2003). The genetic requirement
for VEGFR1 as a VEGF-A receptor specifically in the neural
lineage has not been examined so far, but we know that mice
lacking the tyrosine kinase activity of VEGFR1, similar to mice
lacking neural VEGFR2, undergo at least grossly normal brain
morphogenesis (Hiratsuka et al., 1998). However, a recent study
suggested that VEGFR1 might negatively regulate neurogenesis
(see Glossary, Box 1) by regulating VEGF-A levels (see below)
(Wittko et al., 2009).
The non-tyrosine kinase VEGF-A receptor NRP1 is upregulated
on neurons and endothelium after CNS ischemia (Zhang et al.,
2001), but mouse knockout studies or equivalent physiological
experiments have not yet determined whether neuropilins primarily
act as VEGF-A receptors in these adult situations, or whether they
instead function as receptors for axon guidance molecules of the
class 3 semaphorin family (Raper, 2000). By contrast, several
embryonic studies have provided conclusive evidence that NRP1
does convey VEGF-A signals in subpopulations of developing
neurons, including facial branchiomotor (FBM) neurons, retinal
ganglion cells (RGCs) and gonadotropin-releasing hormone
(GnRH) neurons (see below).
Taken together, it appears that VEGFR1, VEGFR2 and NRP1
are all expressed in distinct subtypes of developing and adult
neurons, but only VEGFR2 and NRP1 have so far been shown to
cell-autonomously affect the behaviour of differentiated neurons
during embryogenesis. Potential roles for the VEGF receptors in
the generation of neurons are discussed in the following section.
VEGF-A and the angiogenic niche of neurogenesis
Two regions in the mammalian brain undergo neurogenesis in
normal adults: the subventricular zone (SVZ; see Glossary, Box 1)



















Fig. 2. Spatiotemporal relationship of angiogenesis and neurogenesis in the embryonic brain. (A)VEGF-A (green circles) is secreted from
neural stem/progenitor cells (small orange cells) as three isoforms that form chemoattractive VEGF-A concentration gradients (grey) as a result of
their differential matrix affinities. These gradients are sensed by endothelial tip cell filopodia at the tips of blood vessels (red) during vessel sprouting
(step 1: sprouting). Microglia (green cell) help neighbouring tip cells to fuse into new vessel loops (step 2: fusion). At the same time, neural
progenitors self-renew or give rise to progeny that differentiate into neurons (arborised orange cell with axon) or glia (stellate orange cell).
(B,C)Alternative hypotheses to explain the coordinated growth of blood vessels and neural tissue in the angiogenic niche during neurogenesis.
(B)VEGF-A from neural progenitors or differentiated neural progeny signals directly back to neural progenitors expressing VEGF-A receptors (red).
(C)Blood vessels growing in response to VEGF-A gradients secrete neurogenic/trophic factors or lay down an extracellular matrix (ECM) that












neurons that are destined to become interneurons; and the dentate
gyrus, which supplies the hippocampus with new neurons that will
participate in memory formation. In both regions, neurogenesis
occurs in close proximity to growing blood vessels (Fig. 2A). This
observation led to the concept of the ‘angiogenic niche of
neurogenesis’ (see Glossary, Box 1) (Palmer et al., 2000). Two
possibilities might explain the association of new vessel growth
with neurogenesis: VEGF-A might stimulate neurogenesis directly
by acting on neural progenitors expressing appropriate receptors,
in analogy to its role in blood vessel growth (Fig. 2B); alternatively,
VEGF-A-induced blood vessels might promote neurogenesis by
providing structural and matrix support or by secreting other
neurogenic factors, in addition to their general role in supplying
oxygen and nutrients (Fig. 2C). These alternative hypotheses need
not be mutually exclusive.
One of the first studies that experimentally validated the existence
of an angiogenic niche for neurogenesis concerned seasonal neuron
production in the higher vocal cord centre (HVC) of adult male
songbirds (Louissaint et al., 2002). In this organ, testosterone
stimulates the secretion of VEGF-A and causes upregulation of
VEGFR2 on HVC blood vessels to increase angiogenesis; the VEGF-
A-stimulated blood vessels in turn secrete brain-derived neurotrophic
factor (BDNF) to support neuronal progenitor recruitment into the
neural networks of the HVC (Hartog et al., 2009; Louissaint et al.,
2002; Rasika et al., 1994). Mechanistically, vessel-derived BDNF is
thought to promote neuronal progenitor migration and, possibly,
survival (Louissaint et al., 2002). Blood vessels may also play a more
structural role, as neural progenitor cells in the adult mouse SVZ
directly contact blood vessels (Mirzadeh et al., 2008) and maintain
close proximity to blood vessels when proliferating (Tavazoie et al.,
2008). Moreover, disrupting this interaction alters the position and
proliferation of these neural progenitors (Shen et al., 2008).
Several other lines of in vitro experimentation support a role for
VEGF-A in adult neurogenesis. Firstly, VEGF-A expression is
upregulated in CNS regions that undergo neurogenesis in rodents
after transplantation of bone marrow-derived mesenchymal stem
cells (Bao et al., 2011), after exercise (Wong-Goodrich et al.,
2010), following traumatic brain injury (Lu et al., 2011) or in
response to environmental enrichment (Cao et al., 2004). Secondly,
manipulating VEGF-A expression alters the level of neurogenesis
in these experimental settings. For example, sequestering
circulating VEGF-A with a soluble VEGFR1 receptor disrupts
exercise-induced neurogenesis (Fabel et al., 2003). Moreover,
delivery of exogenous VEGF-A to the brain enhances neurogenesis
in adult rats, whereas inhibiting VEGF-A expression by siRNA
disrupts neurogenesis, learning and memory formation in healthy
animals (Cao et al., 2004; Sun et al., 2010a) and in rodents with
traumatic brain injury or ischemia (Li et al., 2009; Thau-Zuchman
et al., 2010; Wang et al., 2009; Wang, Y. Q. et al., 2007).
VEGF-A also plays a role in antidepressant therapies that
stimulate neurogenesis. Treatment with several different classes of
antidepressants induces VEGF-A expression, and the
pharmacological inhibition of VEGF-A signalling by
intraventricular infusion of a VEGFR2 inhibitor reduces the neural
stem/progenitor proliferation induced by electroconvulsive
treatment or antidepressant therapy in rodents (Segi-Nishida et al.,
2008; Warner-Schmidt and Duman, 2007). Inhibition of VEGFR2
also blocks stress-related behavioural changes in rats (Greene et al.,
2009). Although it is not known whether VEGF-A levels are
decreased in depression, polymorphic variation in VEGFA might
explain the variable success of antidepressant treatment in humans
(Viikki et al., 2010).
The studies described above imply that VEGF-A is important for
adult neurogenesis. However, VEGF-A and VEGF-A-induced
blood vessel growth may also be important for developmental
neurogenesis. For example, endothelial cells enhance the ability of
embryonic neural progenitors to self-renew in co-culture models
and thereby inhibit their differentiation (Shen et al., 2004).
Neonatal SVZ-derived neural stem cells also proliferate in a
VEGF-A-dependent fashion when co-cultured with endothelial
cells (Sun et al., 2010b).
VEGF-A can also affect neural progenitor migration and
survival. For example, VEGF-A stimulates the migration of
fibroblast growth factor (FGF)-stimulated progenitors from
explanted neonatal rat SVZ (Zhang et al., 2003) and the migration
of a neuroectodermal progenitor cell line derived from a human
cerebellar tumour (Bagnard et al., 2001). In vivo, overexpression
of VEGF-A, either from a recombinant adeno-associated virus
vector in adult rats or from a neuronal Vegfa transgene in mice,
correlates with increased neuronal progenitor migration from the
SVZ after ischemia (Li et al., 2009; Wang, Y. et al., 2007). Whether
this is secondary to VEGF-A enhancing neuronal progenitor
proliferation and/or new progenitor survival is not known.
Furthermore, VEGF-A infusion after traumatic brain injury in rats
decreases the number of apoptotic neurons in the hippocampus
without an appreciable effect on progenitor proliferation (Lee and
Agoston, 2010).
Even though the in vivo studies described above collectively
support the concept of an angiogenic niche of neurogenesis, they
did not unequivocally establish whether VEGF-A acts directly on
neurons that express VEGF-A receptors or instead increases
neurogenesis indirectly by stimulating pro-neurogenic angiogenesis
(Fig. 2B,C). By contrast, it has been convincingly shown that the
closely related factor VEGF-C signals directly to neural stem cells
and niche astrocytes through its receptor VEGFR3 (FLT4)
independently of its alternative roles in lymphatic or blood vessels
(Calvo et al., 2011).
Evidence for direct effects of VEGF-A in neurogenesis
Several in vitro studies have raised the possibility that VEGF-A,
similar to VEGF-C, regulates neurogenesis by acting directly on
neural progenitors, independently of blood vessels. For example,
VEGF-A stimulates the proliferation of primary embryonic cortical
neuronal progenitors in a VEGFR2-dependent manner in the
absence of endothelial cells (Jin et al., 2002). Yet, few studies have
attempted to dissociate VEGF-A-induced angiogenesis and
neurogenesis in a whole-animal context. One study showed that a
low dose of exogenous VEGF-A increased neurogenesis in the
absence of angiogenesis in the SVZ and dentate gyrus, but this was
due to reduced neuronal progenitor apoptosis rather than increased
proliferation (Schanzer et al., 2004). Perhaps the most convincing
evidence that VEGF-A directly increases neuronal progenitor
proliferation in vivo comes from studies in the developing chick
retina, which is devoid of blood vessels throughout much of its
development and can therefore be exploited to analyse vascular-
independent effects of VEGF-A on neurons. The implantation of
VEGF-A-expressing cells into the vitreous humour of E5 chick
eyes mildly increased proliferation, whereas the implantation of
cells expressing a soluble VEGFR2 to sequester VEGF-A or the
infection of chick E1.5 optic vesicles with a virus expressing
dominant-negative VEGFR2 decreased the proliferation of retinal
cells (Hashimoto et al., 2006). Taken together, it appears likely that
VEGF-A can be neurogenic by increasing the proliferation or
decreasing the apoptosis of neural progenitors.












In the developing murine neural retina, VEGFR2 is expressed
in areas of ganglion cell differentiation and blood vessel growth
(Yang and Cepko, 1996), and treatment of the central retina of
perinatal mice with the VEGFR2/VEGFR1 inhibitor SU5416
reduces the retinal vasculature and the thickness of the
nonvascularised peripheral retina (Robinson et al., 2001). Mice
lacking VEGFR1 signalling (Flt1tk–/–) have increased VEGF-A
levels in the brain, which correlates with enhanced neural
progenitor cell proliferation in the SVZ and rostral migratory
stream and leads to an enlarged olfactory bulb; this effect is
likely due to a direct effect of VEGF-A on VEGFR2-expressing
neural progenitors rather than to altered angiogenesis (Wittko et
al., 2009). By contrast, hippocampal neurogenesis is not affected
in Flt1tk–/– mutant mice (Wittko et al., 2009) or by intracerebral
infusion of SU5416 after traumatic brain injury in rats (Lee and
Agoston, 2010). Ultimately, a detailed analysis of cell-specific
VEGF-A receptor knockouts will be required to fully understand
whether VEGF-A is directly neurogenic in the developing or
adult CNS of mammals.
VEGF-A signalling in neuronal patterning
NRP1 serves as a receptor for the VEGF165 isoform on endothelial
cells (Soker et al., 1998) and, together with plexins, acts as a
receptor for semaphorins on neurons (e.g. Kolodkin et al., 1997;
reviewed by Schwarz and Ruhrberg, 2010). Several studies have
tested the idea that VEGF-A also controls neuronal development,
both by binding to NRP1 on neurons and through other VEGF-A
receptors.
VEGF-A regulates neuronal migration
Two independent studies demonstrated that VEGF-A directly
regulates the migration of differentiated neurons, independently
of its roles in neurogenesis or blood vessel growth. The first
study showed that isoform-specific VEGF-A signalling through
NRP1 guides the cell body (soma) of FBM neurons in the
developing mouse brainstem (Fig. 3A) (Schwarz et al., 2004). In
this system, FBM neurons differentiated normally, as
demonstrated by the analysis of transcription factor expression;
moreover, the VEGF164/NRP1-mediated guidance occurred
independently of blood vessels, as an endothelial-specific Nrp1
knockout mouse did not have FBM migration defects (Schwarz
et al., 2004). Intriguingly, VEGF164-NRP1 signalling was
selectively important for FBM cell bodies, but not axons, the
patterning of which was instead controlled by SEMA3A
signalling through NRP1 and plexin A4 complexes (Schwarz et
al., 2004; Schwarz et al., 2008). This observation suggests that
NRP1 preferentially acts as either a VEGF-A or SEMA3A
receptor according to the cellular compartment that it localises
to in these neurons.
A more recent study showed that altering VEGF-A isoform
gradients or overall VEGF-A levels also regulates neuronal
migration (Ruiz de Almodovar et al., 2010). Specifically, altering
the ratio of matrix-binding to diffusible VEGF-A isoforms affects
the migration of newborn granule cell neurons in the mouse
embryo cerebellum (Fig. 3B). Granule cell migration was also
impaired in Vegfadelta/delta mouse mutants with low VEGF-A levels,
although these mice showed normal generation, survival and
differentiation of these neurons and lacked obvious blood vessel
defects in the cerebellum (Ruiz de Almodovar et al., 2010). A
granule cell-specific mouse knockout of Vegfr2 further
demonstrated that the signal-transducing neural VEGF-A receptor
is VEGFR2 (Ruiz de Almodovar et al., 2010).
Together, these studies demonstrated that VEGF-A is a
physiological guidance cue for subpopulations of neurons that acts
independently of its vascular effects or role in neuronal progenitor
proliferation to promote neuronal migration. However, the precise
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Fig. 3. Roles for VEGF-A in neuronal development. (A)The somata of
facial branchiomotor neurons (orange) in rhombomere (r) 4 express NRP1
(dark green outline) and are guided by VEGF-A to r6, where they form
the 7th cranial motor nuclei. Their axons also express NRP1 on the
growth cone (dark red triangle); they extend from the hindbrain into the
second branchial arch, where they are patterned by SEMA3A-mediated
repulsion. (B)Newborn cerebellar granule cells (orange) in the external
granule cell layer (EGL) express VEGFR2 (dark green outline); they are
attracted by VEGF-A gradients emanating from the molecular and
Purkinje layers (ML and PL) to guide them to the internal granule cell layer
(IGL). (C)Retinal ganglion cells (orange) express NRP1 on their growth
cones (dark green triangle) and are guided by VEGF-A across the optic
chiasm to innervate the contralateral brain. Retinal ganglion cells that do
not express NRP1 but express the ephrin receptor EPHB1 on their growth
cones (dark red triangle) are repelled by ephrin B2 at the chiasm and thus
project ipsilaterally. The position of the optic chiasm is determined by
SLIT1/2 expression. (D)Spinal cord commissural axons (orange) express
VEGFR2 on their growth cone (dark green triangle) and are guided by
VEGF-A across the midline. (E)A subpopulation of newly born
gonadotropin-releasing hormone neurons (orange) expresses NRP1 (dark
green outline) and requires VEGF-A survival signals, which are present
along the migratory path, to survive the journey from the vomeronasal












molecular mechanism involved differs between neurons. Further
studies will be necessary to determine whether VEGF-A-mediated
neuronal guidance is of widespread significance for the CNS or
affects only a few subsets of neurons.
VEGF-A in axon guidance
Although it has been reported that VEGF-A promotes neurite
outgrowth from perinatal dorsal root ganglion explants containing
VEGFR2-positive sensory neurons (Sondell et al., 1999a), a
subsequent study showed that VEGFR2 expression in these ganglia
is restricted to endothelial cells, and that VEGF-A sequestration
with soluble VEGFR2 or VEGFR2 inhibition with a small
molecular inhibitor only impaired endothelial, and not axon,
growth (Kutcher et al., 2004). Consistent with the latter study,
cranial sensory and limb axons grow normally in the absence of the
NRP1-binding isoform VEGF164 (Schwarz et al., 2004; Vieira et
al., 2007). Taken together, the in vivo data suggest that VEGF-A
signalling through NRP1 is not important for axon guidance in the
peripheral nervous system (PNS), but studies in mice lacking
neuronal VEGFR2 are required to unequivocally exclude a role for
VEGF-A signalling through this receptor in the PNS.
Several studies, however, agree that VEGF-A plays a role in the
autonomous nervous system. Thus, exogenous VEGF-A increases
neurite outgrowth from sympathetic ganglion explants (Long et al.,
2009) and promotes sympathetic axon growth for re-innervation of
surgically denervated femoral arteries in adult rats (Marko and
Damon, 2008). VEGF-A also promotes the sympathetic regulation
of resistance arteries, as their constriction is reduced in response to
cold stress in Vegfadelta/delta mice with low levels of endogenous
VEGF-A (Storkebaum et al., 2010). However, this defect is not due
to abnormal sympathetic axon guidance but rather to defective
neuromuscular effector junctions (Storkebaum et al., 2010). It is
not yet known whether defective sympathetic regulation of blood
flow in the CNS is also the underlying cause of the reduced brain
and spinal cord perfusion in Vegfadelta/delta mice.
The first physiological evidence that VEGF-A directly guides
CNS axons in vivo was provided by two recent studies on
commissural axon (see Glossary, Box 1) guidance in the mouse
(Erskine et al., 2011; Ruiz de Almodovar et al., 2011). Thus,
VEGF-A helps RGC axons destined for the opposite brain
hemisphere to migrate through the optic chiasm, which is the
diencephalic midline structure where the optic nerves from both
eyes partially cross (Fig. 3C) (Erskine et al., 2011). VEGF-A also
promotes midline crossing of axons in the spinal cord (Fig. 3D)
(Ruiz de Almodovar et al., 2011). Both studies combined genetic
and explant experiments to demonstrate that VEGF-A promotes
axon guidance independently of its vascular roles. Even though
VEGF-A acts through VEGFR2 on spinal commissural axons
(Ruiz de Almodovar et al., 2011), it requires NRP1 to guide
contralateral RGC axons (Erskine et al., 2011). The observation
that embryonic RGC axons use NRP1 was surprising, as in vitro
studies suggested that VEGFR2 is important for the regeneration
of postnatal RGC neurons after axotomy (Bocker-Meffert et al.,
2002). The neuronal VEGF-A receptor used to mediate VEGF-A
signals might therefore vary according to neuron type and
developmental stage.
VEGF-A as a survival factor for developing and adult
neurons
VEGF-A is a potent survival factor for many neuronal populations
in vitro. For example, VEGF-A promotes neuronal survival in
explanted CNS (Rosenstein et al., 2003; Silverman et al., 1999) and
PNS (Sondell et al., 1999a; Sondell et al., 2000) tissue. VEGF-A
also protects stressed neurons in culture, for example after serum
withdrawal (Jin et al., 2000a), hypoxia (e.g. Jin et al., 2000b;
Svensson et al., 2002), mechanical trauma (Ma et al., 2011),
chemical toxicity (Cui et al., 2011), or excitotoxicity caused by
glutamate or the glutamate mimetic AMPA (Bogaert et al., 2010;
Matsuzaki et al., 2001; Svensson et al., 2002). As these culture
models did not contain blood vessels, it was concluded that the
neuronal survival effects of VEGF-A were vessel independent.
Consistent with a role for VEGF-A in neuroprotection,
Vegfadelta/delta mice with reduced levels of VEGF-A suffer late-onset
motoneuron degeneration (Oosthuyse et al., 2001). Additionally,
VEGF-A treatment protects against AMPA-induced or ischemia-
induced motoneuron degeneration in vivo (Lambrechts et al., 2003;
Tovar-y-Romo et al., 2007). VEGF-A also protects against the effect
of the G93A-SOD1 mutation that causes motoneuron degeneration
in a mouse model of ALS (Azzouz et al., 2004). However, none of
these in vivo studies directly distinguished whether the protective
effects of VEGF-A are due to direct effects of VEGF-A on
motoneurons, as observed in vitro, or whether neuroprotection was
due to improved vascular performance. By contrast, VEGF-A does
appear to play a direct role in neuroprotection of newborn dentate
gyrus neurons, as VEGF-A infusion into the hypoxic adult rat brain
enhances the survival of these neurons without inducing
angiogenesis in this region (Sun et al., 2003).
The first unequivocal evidence that VEGF-A conveys
physiological survival signals in neurons expressing VEGF-A
receptors was provided by the finding that mice lacking VEGF164
or NRP1 in the neural lineage contain reduced numbers of GnRH
neurons, which are essential for gonad development and fertility
(Fig. 3E) (Cariboni et al., 2011). Treatment of immortalised GnRH
neurons showed that VEGF164 enhanced survival, but not
proliferation, and that the survival pathways involved co-activating
phosphoinositide 3-kinase and mitogen-activated protein kinase
signalling in an NRP1-dependent fashion (Cariboni et al., 2011). In
agreement with the in vitro findings, apoptotic bodies were
abundant along the VEGF-A-positive path that is taken by these
neurons during embryogenesis as they travel from their birthplace
in the nasal cavity to their destination in the hypothalamus
(Cariboni et al., 2011). Importantly, this study also showed that
mice lacking VEGFR2 in the neural lineage or NRP1 in blood
vessels contained normal numbers of these neurons, establishing
that VEGF164 signals through NRP1 in a cell-autonomous fashion,
independently of vascular VEGF-A signalling or blood vessels.
New roles for VEGF-A in dendritogenesis and neuronal
function
The observation that VEGF-A promotes neurite extension and
upregulates expression of the dendrite-enriched microtubule-
associated protein MAP2 (MTAP2) in vitro (Rosenstein et al.,
2003) raised the possibility that VEGF-A affects dendrite and
synapse development. Several studies have since begun to
investigate the role of VEGF-A signalling in dendritogenesis and
synaptic function. In vitro, administration of VEGF-A modulates
calcium channels in hippocampal neurons (Kim et al., 2008; Ma et
al., 2011) and upregulates the AMPA receptor subunit GluR2
(GRIA2) (Bogaert et al., 2010). VEGF-A also reduces stimulus-
evoked depolarisation of hypoglossal motoneurons in organotypic
slice culture (McCloskey et al., 2008). Interestingly, upregulation
of VEGF-A through hypoxia-induced factor HIF1A enhances
synaptic transmission in hippocampal neurons in vitro (Huang et
al., 2010), suggesting that hypoxia regulates synaptic transmission












via VEGF-A. Consistent with this idea, VEGF-A administration
increases phrenic nerve output in adult rats to regulate spinal
respiratory functions (Dale-Nagle et al., 2011). In vivo, blocking
VEGF-A activity by antibody administration also increases pain
thresholds after chronic nerve constriction injury in rats (Lin et al.,
2010).
The first in vivo evidence that VEGF-A promotes dendrite
patterning came from a recent study in mice which showed that the
forced expression of soluble VEGFR1 impairs dendrite
development of newly born neurons migrating from the SVZ to the
olfactory bulb, independently of vascular changes (Licht et al.,
2010). A similar approach was subsequently used to show that
VEGF-A increases synaptic strength independently of neurogenesis
and angiogenesis to promote hippocampus-dependent memory
formation (Licht et al., 2011). Together, these studies point to a
crucial role for VEGF-A in dendrite development and synaptic
plasticity, but further work will be required to elucidate the VEGF-
A receptors and downstream signalling pathways involved.
VEGF-A in neurovascular co-patterning
Studies in genetically modified mouse embryos revealed that
nerve-secreted VEGF-A acts on vascular NRP1 to promote arterial
differentiation adjacent to sensory nerves in the limb skin
(Mukouyama et al., 2005; Mukouyama et al., 2002). However, the
factors that control the nerve-vessel co-alignment prior to arterial
differentiation have remained elusive. Unpublished evidence
presented in a recent review on neurovascular cross-talk suggests
that the Schwann cell-derived chemokine CXCL12 activates its
receptor CXCR4 on a subset of blood vessels to promote nerve-
vessel co-alignment (James and Mukouyama, 2011). Whether
VEGF-A also controls the co-patterning of arteries and nerves in
the CNS is not known.
Conclusions
The studies described in this review demonstrate that VEGF-A plays
multiple roles in the developing and adult nervous system by acting
both on blood vessels and neurons. Interestingly, VEGF-like
orthologues function in the nervous system of invertebrates, which
do not have a vascular system other than a heart tube, e.g.
Caenorhabditis elegans (Popovici et al., 2002; Procko et al., 2011).
It is therefore possible that the VEGF family was used to shape the
nervous system before it was adapted to induce and regulate the
vasculature. If this hypothesis is correct, it seems likely that further
roles for VEGF-A at different stages in the life of different neuronal
subtypes remain to be discovered. Importantly, the dual effect of
VEGF-A on neurons and blood vessels could be both beneficial and
detrimental in a therapeutic context. Using anti-VEGF-A therapy to
treat unwanted angiogenesis and vascular leakage in cancer and eye
diseases might inadvertently inhibit adult neurogenesis and/or
neuroprotection. On the other hand, VEGF-A could be used to treat
neurodegenerative and neuropathic conditions by simultaneously
enhancing blood vessel growth, neurogenesis and neuroprotection,
provided that we learn to control its potential negative effects. Most
importantly, VEGF-A can increase vascular permeability and thereby
disrupt the blood-brain barrier and promote inflammatory cell
infiltration (Kalaria et al., 1998; Krum and Khaibullina, 2003; Krum
et al., 2002; Proescholdt et al., 1999; Zhang et al., 2000). Defining
the role of VEGF-A and its receptors in neurodevelopment and in
adult neural homeostasis and pathology is therefore a priority for the
future. Specifically, delineating the components of downstream
signalling pathways activated by VEGF-A binding to its receptors in
neurons versus endothelial cells, and in angiogenesis versus vascular
permeability, will help to pioneer novel therapeutic strategies that
selectively affect subsets of VEGF-A responses to promote effective
and safe nervous system repair.
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